Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Can This J&J Drug Reshape Schizophrenia Treatment?
Investopedia
Thu, 05/21/15 - 12:46 pm
Tags:
JNJ, schizophrenia, Invega Trinza
Will the J&J Deal With Achillion Transform the Hep C Market?
WSJ Pharmalot
Thu, 05/21/15 - 09:50 am
Tags:
JNJ, hepatitis C, Achillion
Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Fierce Pharma Marketing
Wed, 05/20/15 - 06:15 pm
Tags:
Medivation, Xtandi, Astellas, JNJ, Zytiga
J&J: 10 new drugs by 2019, each with $1B potential
CNBC
Wed, 05/20/15 - 09:54 am
Tags:
JNJ, Alex Gorsky, Pharma CEOs
Achillion partners with J&J to develop hep C drugs
Yahoo/Reuters
Tue, 05/19/15 - 06:23 pm
Tags:
Achillion, JNJ, R&D, hepatitis C
J&J nears $7.5M deal in Risperdal case that could have cost $1.2B
Fierce Pharma
Tue, 05/19/15 - 11:08 am
Tags:
JNJ, Risperdal
Johnson & Johnson Headed Even Higher After Big-Volume Lift
TheStreet.com
Tue, 05/19/15 - 10:45 am
Tags:
JNJ
FDA approves longer-acting version of J&J's schizophrenia drug
Yahoo/Reuters
Tue, 05/19/15 - 10:35 am
Tags:
FDA, JNJ, schizophrenia, Invega Trinza
FDA's SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
Fierce Pharma
Mon, 05/18/15 - 09:40 pm
Tags:
FDA, SGLT2 inhibitor, AstraZeneca, JNJ, Eli Lilly, Merck, diabetes
The top 10 advertisers in Big Pharma
Fierce Pharma Marketing
Mon, 05/18/15 - 11:27 am
Tags:
Pfizer, AbbVie, AstraZeneca, Eli Lilly, JNJ, Actavis, Merck, Bristol-Myers Squibb, Dainippon Sumitomo, Amgen, drug ads
Should Eliquis' surge make Xarelto fans very, very afraid? Not really, analyst says
Fierce Pharma Marketing
Mon, 05/18/15 - 10:37 am
Tags:
Eliquis, Xarelto, bloodthinners, Bayer, JNJ, Pfizer, Bristol-Myers Squibb
The FDA's Authority Challenged By Mallinckrodt
Yahoo/Benzinga
Sat, 05/16/15 - 02:06 pm
Tags:
FDA, Mallinckrodt, JNJ, Concerta, ADHD, generics
FDA warns on newer class of type 2 diabetes drugs
Yahoo/Reuters
Sat, 05/16/15 - 02:04 pm
Tags:
FDA, diabetes, type 2 diabetes, AstraZeneca, Farxiga, Eli Lilly, Jardiance, Boehringer Ingelheim, JNJ, Invokana, SGLT2 inhibitor
Generic ADHD Drug Maker Locks Horns With FDA
WSJ Pharmalot
Fri, 05/15/15 - 09:24 am
Tags:
generics, ADHD, FDA, Concerta, Actavis, JNJ
Galapagos inflates IPO again as AbbVie, J&J jockey for position
Fierce Biotech
Thu, 05/14/15 - 11:02 am
Tags:
Galapagos, IPOs, AbbVie, JNJ
J&J Among Drug Makers Getting Chicago's Opiates Suit Tossed
Yahoo/Bloomberg
Sat, 05/9/15 - 09:49 am
Tags:
JNJ, opioids, Actavis, Purdue, painkillers, chicago, oxycontin
J&J Changes ‘Compassionate’ Care
WSJ Online
Thu, 05/7/15 - 10:51 am
Tags:
JNJ, compassionate use guidelines
J&J's 2018 Remicade patent smacked down at PTO again
Fierce Pharma
Fri, 05/1/15 - 08:54 am
Tags:
JNJ, Remicade, patents, PTO
Globus: Witness for J&J's Synthes faked credentials
Mass Device
Tue, 04/28/15 - 09:04 pm
Tags:
JNJ, Synthes, devices, patents, spinal implants
DepoMed Set To Grow On 'Transformative' Nucynta Deal
Investors.com
Fri, 04/24/15 - 10:33 am
Tags:
Depomed, Nucynta, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.